Evidence map›Paper›PMID 41237656›Full record

ArticleJournal of health economics2025

Contraceptive access and infant health outcomes.

James Flynn

Abstract read
In one paragraph

Article in Journal of health economics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

James FlynnMiami University, United States of America; IZA, Germany. Electronic address: flynnj@miamioh.edu.

Funding

University of Colorado Population CenterP2CHD066613 · NICHD · UNIVERSITY OF COLORADO · PI JANE A MENKEN · 2015 to 2026
$3.7M
Increased access to highly effective contraception: an opportunity dividend?R01HD101480 · NICHD · UNIVERSITY OF COLORADO · PI STEVENSON, AMANDA JEAN · 2020 to 2024
$2.5M
NICHD NIH HHS P2C HD066613NICHD NIH HHS R01 HD101480
6 · The paper itself

Abstract

This paper documents an important unintended consequence of expanding contraceptive access; it reduces the rates of adverse infant health outcomes. I study a large family planning initiative in the St. Louis metropolitan area that provided thousands of long-acting reversible contraceptives (LARCs) to reproductive-age women at no cost. Using a synthetic difference-in-differences design, I find that the program led to substantial improvements in infant health, reducing extremely preterm births by 2.18 and infant deaths by 1.74 per 1,000 live births, reductions of approximately 20% for each outcome. I find meaningful reductions for both Black and White mothers, though the effects on Black mothers are less precisely estimated and are smaller as a percentage of the baseline rates, particularly for extremely preterm births.

Indexed as

Family Planning ServicesHealth Services AccessibilityInfant HealthLong-Acting Reversible ContraceptionAdolescentAdultBlack or African AmericanFemaleHumansInfantInfant MortalityInfant, NewbornMissouriPregnancyWhiteYoung AdultContraceptive accessFamily planningInfant mortalityPreterm birth

Identifiers

PMID41237656
PMCPMC13417695

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.